These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2885890)

  • 1. Serum neuroleptic and anticholinergic activity in relationship to cognitive toxicity of antiparkinsonian agents in schizophrenic patients.
    Hitri A; Craft RB; Fallon J; Sethi R; Sinha D
    Psychopharmacol Bull; 1987; 23(1):33-7. PubMed ID: 2885890
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.
    McEvoy JP
    J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients.
    Hitri A; Craft RB; Sethi R; Sinha D
    Clin Neuropharmacol; 1987 Jun; 10(3):261-71. PubMed ID: 2900683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP; McCue M; Freter S
    Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic effects on memory: benztropine versus amantadine.
    Gelenberg AJ; Van Putten T; Lavori PW; Wojcik JD; Falk WE; Marder S; Galvin-Nadeau M; Spring B; Mohs RC; Brotman AW
    J Clin Psychopharmacol; 1989 Jun; 9(3):180-5. PubMed ID: 2661606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychoactive properties of benztropine and trihexyphenidyl.
    Wilcox JA
    J Psychoactive Drugs; 1983; 15(4):319-21. PubMed ID: 6655530
    [No Abstract]   [Full Text] [Related]  

  • 7. Actions of trihexyphenidyl and benztropine on squid axon membranes.
    Wu CH; Narahashi T
    J Pharmacol Exp Ther; 1976 Apr; 197(1):135-41. PubMed ID: 1263127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mood elevation and medication.
    Dugas JE
    Dis Nerv Syst; 1977 Nov; 38(11):958. PubMed ID: 21060
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms.
    Fayen M; Goldman MB; Moulthrop MA; Luchins DJ
    Am J Psychiatry; 1988 Apr; 145(4):483-6. PubMed ID: 2894780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cognitive toxicity of anticholinergic drugs.
    Katz IR; Greenberg WM; Barr GA; Garbarino C; Buckley P; Smith D
    J Clin Psychiatry; 1985 Aug; 46(8):323-6. PubMed ID: 2862135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance.
    Adler G; Grieshaber S; Faude V; Thebaldi B; Dressing H
    Pharmacopsychiatry; 2002 Sep; 35(5):190-4. PubMed ID: 12237790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic effects on memory: benztropine vs. amantadine.
    Van Putten T; Gelenberg AJ; Lavori PW; Falk WE; Marder SR; Spring B; Mohs RC; Brotman AW
    Psychopharmacol Bull; 1987; 23(1):26-9. PubMed ID: 3602326
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers.
    McEvoy JP; McCue M; Spring B; Mohs RC; Lavori PW; Farr RM
    Am J Psychiatry; 1987 May; 144(5):573-7. PubMed ID: 3578566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncompliance with antiparkinsonian medications in neuroleptic-treated schizophrenic patients: three cases of an unreported phenomenon.
    Bermanzohn PC; Siris SG
    J Clin Psychiatry; 1994 Nov; 55(11):488-91. PubMed ID: 7989282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.
    Tune LE; Strauss ME; Lew MF; Breitlinger E; Coyle JT
    Am J Psychiatry; 1982 Nov; 139(11):1460-2. PubMed ID: 6127957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergics promote neuroleptic-induced tardive dyskinesia.
    Borison RL; Diamond BI
    Adv Biochem Psychopharmacol; 1980; 24():359-61. PubMed ID: 6105786
    [No Abstract]   [Full Text] [Related]  

  • 18. The dose-response relationship for memory impairment by anticholinergic drugs.
    McEvoy JP; Freter S
    Compr Psychiatry; 1989; 30(2):135-8. PubMed ID: 2920548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy.
    Manos N; Gkiouzepas J; Logothetis J
    Am J Psychiatry; 1981 Feb; 138(2):184-8. PubMed ID: 6109453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neuroleptic levels in the maintenance treatment of schizophrenia.
    Brown WA; Laughren T
    Psychopharmacol Bull; 1983; 19(1):76-8. PubMed ID: 6131471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.